Rochester, Minnesota
United States
40
2026-05-07
The entities that hold a legal rights for patent applications filed by inventor Behfar Atta:
Atta Behfar from Rochester, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOSITIONS AND METHODS FOR WOUND HEALING
#2 | 2026-03-12MAKING AND USING CARDIOPOIETIC CELLS
#3 | 2026-01-15COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES
#4 | 2025-10-02REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#5 | 2025-10-02REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#6 | 2025-09-18COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIAL TISSUE
#7 | 2025-09-18PURIFIED EXOSOME PRODUCTS, METHOD OF MAKING, AND METHODS OF USING
#8 | 2025-05-15COMPOSITIONS AND METHODS FOR MODULATING THE IMMUNE SYSTEM
#9 | 2025-01-23COMPOSITIONS AND METHODS FOR TREATING EXPOSURE OF SURGICAL MESH
#10 | 2025-01-16COMPOSITIONS AND METHODS FOR REPAIRING DAMAGE TO SKELETAL MUSCLE
#11 | 2025-01-09METHODS AND COMPOSITIONS FOR REPAIR OF TENDON-BONE INTERFACE
#12 | 2025-01-09COMPOSITIONS AND METHODS FOR TENDON REPAIR
#13 | 2024-11-28PARTICLE-MEDIATED DELIVERY OF BIOLOGICS
#14 | 2024-09-26PURIFIED EXOSOME PRODUCTS, METHOD OF MAKING, AND METHODS OF USING
#15 | 2024-01-04COMPOSITIONS AND METHODS PROMOTING GROWTH OF PERIPHERAL NERVOUS TISSUE
#16 | 2023-12-14METHODS AND MATERIALS FOR TREATING HEART FAILURE
#17 | 2022-10-27REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#18 | 2022-08-04ANTIOXIDANT AND ANTIVIRAL COMPOSITIONS AND METHODS
#19 | 2022-05-19Particle-mediated delivery of biologics
#20 | 2021-11-11MAKING AND USING CARDIOPOIETIC CELLS
#21 | 2021-09-09CIRCULARIZED ENGINEERED RNA AND METHODS
#22 | 2021-08-26COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES
#23 | 2021-07-08MICROENCAPSULATED MODIFIED POLYNUCLEOTIDE COMPOSITIONS AND METHODS
#24 | 2021-06-10Purified exosome products, method of making, and methods of using
#25 | 2020-11-12Using nucleic acids encoding NAP-2 polypeptides to improve cardiac function
#26 | 2019-11-07PERCUTANEOUSLY-DEPLOYABLE INTRAVASCULAR EMBOLIC PROTECTION DEVICES AND METHODS
#27 | 2019-09-12PARTICLE-MEDIATED DELIVERY OF BIOLOGICS
#28 | 2018-08-02NAP-2 polypeptides and methods for modulating immune system activity in heart tissue
#29 | 2016-11-10Exosome delivery technology
#30 | 2016-10-13METHOD FOR DETERMINING THE CARDIO-GENERATIVE POTENTIAL OF MAMMALIAN CELLS
#31 | 2016-08-04NOVEL CONCEPT TO REDUCE LEFT ATRIAL PRESSURE IN SYSTOLIC AND DIASTOLIC HF PATIENTS TO TREAT PULMONARY EDEMA AND REDUCE HOSPITALIZATION RATES
#32 | 2016-07-21Using nucleic acids encoding NAP-2 and TGF-alpha polypeptides to improve cardiac function
#33 | 2015-12-17MULTIFUNCTIONAL OCCLUSION CROSSOVER DEVICE
#34 | 2014-11-27Compositions and methods for obtaining cells to treat heart tissue
#35 | 2012-07-12Treating cardiovascular tissue
#36 | 2012-04-26METHOD FOR DETERMINING THE CARDIO-GENERATIVE POTENTIAL OF MAMMALIAN CELLS
#37 | 2011-05-19Compositions and methods for obtaining cells to treat heart tissue
#38 | 2010-07-29CARDIAC-SPECIFIC PROGENITOR CELLS
#39 | 2008-09-04Compositions consisting essentially of TGF-β, BMP-2 FGF-4, leukemia inhibitory factor, IGF-1, IL-6 and H-α-thrombin
#40 | 2008-01-24Methods and materials for providing cardiac cells
982472 ⎘